Calendario de eventos




FierceBiotech Roundtable Webinar: ​ESMO Post-Show: Highlights from the virtual conference

Jill O'Donnell-Tormey, PhD, CEO and director of scientific affairs, speaks on the "​ESMO Post-Show" webinar on September 22, 2020, at 3 PM ET.

Watch the Webinar

Cancer experts and pharma execs will break down the headline-making data from ESMO, sharing their insights and analysis around the conference’s most closely watched studies. This discussion will examine how groundbreaking research unveiled over the weekend will change clinical practice and prime drugs for key new indications, and panelists will fill you in on the need-to-know takeaways from oncology’s hottest fields.

Featured Speakers

Daina Graybosch, PhD
Managing Director, Immuno-Oncology
SVB Leerink

Daina Graybosch, PhD, is a Senior Research Analyst at SVB Leerink covering Immuno-Oncology.

Prior to joining the firm in 2018, Dr. Graybosch worked at McKinsey & Company as a Senior Expert and Head of Mckinsey’s Center for Asset Optimization, as well as the U.S. Head of the McKinsey Cancer Center. In these roles, Dr. Graybosch developed several McKinsey solutions that bring data and advanced analytics to pharmaceutical development decisions. In her 11 years at McKinsey, Dr. Graybosch developed a rich understanding of oncology through her work with companies across the value chain, including Pharmaceutical, Diagnostic, Academic Medical Center, and Genomic/Data.

Dr. Graybosch earned a PhD in Chemistry and Chemical Biology from Harvard University and dual B.S. degrees in Biology and Chemistry from the University of Utah.

Jill O'Donnell-Tormey, PhD
Chief Executive Officer and Director of Scientific Affairs
Cancer Research Institute

Jill O’Donnell-Tormey, PhD, is chief executive officer and director of scientific affairs of the Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that is today the global leader in supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers. She joined the organization in 1987, and has been chief executive since 1993. Prior to joining CRI, she served as a research associate in the department of medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University.

Leer más:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.